Compugen Posts Declining Revenue, Widened Loss in Q4

genomeweb
360dx

Compugen Posts Declining Revenue, Widened Loss in Q4

Feb 13, 2002

NEW YORK, Feb. 13 - Compugen on Wednesday reported that revenue shrank in the fourth quarter as a moderate increase in R&D spending conspired to widen net losses.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

FDA Clears NeuMoDx MDx System, GBS Assay
Biocept, UCSD to Study Liquid Biopsy to Predict Cancer Recurrence, Therapy Response
Waters Acquires Rights to Prosolia DESI Technology for Mass Spec
Palmetto Issues Positive Final LCD for MDxHealth Prostate Cancer Test
Clearbridge Signs China Distribution, Test Development Deal with Agen Lab
Top Five Articles on GenomeWeb Last Week: Foundation Medicine, WGD, CRISPR, and More

The Scan

Human Longevity Sues JCVI

Human Longevity alleges that Craig Venter stole trade secrets in a lawsuit filed against the J. Craig Venter Institute.

Atacama Mummy Study Criticized

A new paper critiques the analysis and conclusions of the Atacama mummy genome sequencing study.

This Week in PLOS

In PLOS this week: transcription levels linked to uracil mutations, transcriptomic analysis of medicinal leech, and more.

Want to Know

An Associated Press poll finds that most US adults say they'd want to know whether they carried a gene variant predisposing them to an incurable disease.

Main menu